News As Brexit trigger nears, UK pharma prepares for different sc... AstraZeneca chief considers two possible scenarios for post-Brexit regulation
News Prime minister accused of being "in denial" about NHS crisis PM under fire over A&E waiting times.
Views & Analysis ‘Quickie divorce’ Brexit not an option for medicines, says U... The UK government wants a 'bespoke' deal for pharma - but the EU has other ideas.
News UK could seek ‘transitional deal’ to cushion Brexit PM also promises corporation tax cuts and innovation investment
Views & Analysis What doctors say about Theresa May’s reappointment of Jeremy... Reactions of healthcare professionals to Jeremy Hunt staying as Health Secretary.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
